964 related articles for article (PubMed ID: 29748958)
41. Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness.
Matsushita R; Yoshino H; Enokida H; Goto Y; Miyamoto K; Yonemori M; Inoguchi S; Nakagawa M; Seki N
Oncotarget; 2016 May; 7(19):28460-87. PubMed ID: 27072587
[TBL] [Abstract][Full Text] [Related]
42. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
[TBL] [Abstract][Full Text] [Related]
43. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.
Qu K; Zhang X; Lin T; Liu T; Wang Z; Liu S; Zhou L; Wei J; Chang H; Li K; Wang Z; Liu C; Wu Z
Sci Rep; 2017 May; 7(1):1692. PubMed ID: 28490741
[TBL] [Abstract][Full Text] [Related]
44. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
45. GR silencing impedes the progression of castration-resistant prostate cancer through the JAG1/NOTCH2 pathway via up-regulation of microRNA-143-3p.
Zhang L; Jiang H; Zhang Y; Wang C; Xia X; Sun Y
Cancer Biomark; 2020; 28(4):483-497. PubMed ID: 32568179
[TBL] [Abstract][Full Text] [Related]
46. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.
Cochetti G; Poli G; Guelfi G; Boni A; Egidi MG; Mearini E
Onco Targets Ther; 2016; 9():7545-7553. PubMed ID: 28008272
[TBL] [Abstract][Full Text] [Related]
47. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
[TBL] [Abstract][Full Text] [Related]
49. Identification of miR-1-3p, miR-143-3p and miR-145-5p association with bone metastasis of Gleason 3+4 prostate cancer and involvement of LASP1 regulation.
Guo H; Zhao J; Li X; Sun F; Qin Y; Yang X; Xiong X; Yin Q; Wang X; Gao L; Jiao M; Hu J; Han B
Mol Cell Probes; 2023 Apr; 68():101901. PubMed ID: 36791996
[TBL] [Abstract][Full Text] [Related]
50. miRNA-146a-5p is upregulated in serum and cartilage samples of patients with osteoarthritis.
Skrzypa M; Szala D; Gablo N; Czech J; Pajak J; Kopanska M; Trzeciak M; Gargasz K; Snela S; Zawlik I
Pol Przegl Chir; 2019 Feb; 91(3):1-5. PubMed ID: 31243168
[TBL] [Abstract][Full Text] [Related]
51. Carboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot Study.
Benson EA; Skaar TC; Liu Y; Nephew KP; Matei D
PLoS One; 2015; 10(10):e0141279. PubMed ID: 26485143
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
53. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
[TBL] [Abstract][Full Text] [Related]
54. Decreased miR-218-5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer.
Peng P; Chen T; Wang Q; Zhang Y; Zheng F; Huang S; Tang Y; Yang C; Ding W; Ren D; Huang Z; Guo Y
Oncol Res Treat; 2019; 42(4):165-185. PubMed ID: 30870834
[TBL] [Abstract][Full Text] [Related]
55. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
Heinemann FG; Tolkach Y; Deng M; Schmidt D; Perner S; Kristiansen G; Müller SC; Ellinger J
Clin Epigenetics; 2018; 10():11. PubMed ID: 29410711
[TBL] [Abstract][Full Text] [Related]
56. Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer.
Zedan AH; Osther PJS; Assenholt J; Madsen JS; Hansen TF
Sci Rep; 2020 Jan; 10(1):227. PubMed ID: 31937854
[TBL] [Abstract][Full Text] [Related]
57. miR-214-5p inhibits human prostate cancer proliferation and migration through regulating CRMP5.
Zheng C; Guo K; Chen B; Wen Y; Xu Y
Cancer Biomark; 2019; 26(2):193-202. PubMed ID: 31403941
[TBL] [Abstract][Full Text] [Related]
58. Predictive Value of Circulating miRNAs in Lymph Node Metastasis for Colon Cancer.
Lee IH; Kim G; Kwak SG; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Hur K; Kim JG
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513887
[TBL] [Abstract][Full Text] [Related]
59. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer.
Hussein NA; Kholy ZA; Anwar MM; Ahmad MA; Ahmad SM
J Cancer Res Clin Oncol; 2017 Jan; 143(1):83-93. PubMed ID: 27631726
[TBL] [Abstract][Full Text] [Related]
60. Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway.
Yang Z; Qu CB; Zhang Y; Zhang WF; Wang DD; Gao CC; Ma L; Chen JS; Liu KL; Zheng B; Zhang XH; Zhang ML; Wang XL; Wen JK; Li W
Oncogene; 2019 Apr; 38(14):2516-2532. PubMed ID: 30531834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
